A case report of severe nasal ischemia from cold agglutinin disease and a novel treatment protocol including HBOT

0Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cold agglutinin disease (CAD) is a rare condition leading to blood agglutination and autoimmune hemolytic anemia. Cutaneous ischemia resulting from CAD in the head and neck is uncommon. Treatment regimens and outcomes vary widely in the literature and no clear protocol exists. This manuscript describes a patient with CAD who developed severe ischemia of the nose that resolved completely without sequellae following a medical regimen of aspirin, low molecular weight heparin, nitroglycerin ointment and hyperbaric oxygen therapy (HBOT). To our knowledge, this is the first reported case where nitroglycerin ointment or HBOT was successfully employed in the treatment of this complication.

Cite

CITATION STYLE

APA

Kohlert, S., McLean, L., Scarvelis, D., & Thompson, C. (2019). A case report of severe nasal ischemia from cold agglutinin disease and a novel treatment protocol including HBOT. Journal of Otolaryngology - Head and Neck Surgery, 48(1). https://doi.org/10.1186/s40463-019-0369-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free